Oliver Bohnsack und Recist - Info zur Person

(1 - 11 von 14

)

[PDF] Derivation of Efficacy Endpoints by iRECIST Criteria - PharmaSUGwww.pharmasug.org › proceedings › PharmaSUG SA-015

www.pharmasug.org

Maio, Michael Binder, Oliver Bohnsack, Geoffrey Nichol, Rachel Humphrey and F. Stephen Hodi. Guidelines for the Evaluation of Immune Therapy Activity in ...

No relevant relationships to disclose

apps.asco.org

Adaptation and modification of the immune related response criteria (IRRC): IrRECIST. Oliver Bohnsack. No relevant relationships to disclose. Axel Hoos. › coidisplay

Improving response evaluation in oncology trials - YouTubewww.youtube.com › watch

www.youtube.com

· RECIST expert Dr. Oliver Bohnsack discusses a recent study that demonstrated the survival ...Dauer: 26:55Gepostet:

Twitter-Nachrichten: Calyx on Twitter: "Learn from RECIST expert, Dr. Oliver ...

— Learn from RECIST expert, Dr. Oliver Bohnsack how response evaluation in #oncology research can be improved – and in many cases, ... › calyxai › status

Calyx Cafe on Apple Podcasts

podcasts.apple.com

RECIST expert Dr. Oliver Bohnsack discusses a recent study that demonstrated the survival benefit to a subgroup of patients when irRECIST is used instead of ... › podcast

Solid Tumor Trials: Maintain More Patients with irRECIST

event.on24.com

Oliver Bohnsack of Calyx – a leading expert on RECIST and irRECIST – discusses the implications of these findings, what it means for oncology clinical ... Oliver Bohnsack, MD PhD MBA Vice President, Medical Imaging and Head of Oncology Calyx. In leading the imaging component of oncology studies for Calyx's ... › wcc

1070padaptation of the immune related response criteria: irrecist.www.semanticscholar.org › paper

www.semanticscholar.org

· author={Oliver Bohnsack and Axel Hoos and Katarina Ludajic}, journal={Annals of oncology : official journal of the European Society for ...

在晚期肝细胞癌中使用mRECIST 与RECIST 1.1 标准的反应比较

www.x-mol.com

Jayant Narang 1 , Surabhi Bajpai 2 , Rudresh Jarecha 2 , Manish Sharma 3 , Oliver Bohnsack 4. Affiliation. Parexel Informatics Inc, Rochester, NY; ... › paper

RECIST in the Real World - Applied Clinical Trialswww.appliedclinicaltrialsonline.com › view › recist-...

www.appliedclinicaltrialsonline.com

· Oliver Bohnsack,* MD, PhD, MBA, is Senior Medical Director, Head of Oncology, email: [email protected], and Annette Schmid, PhD, ...

Improving how we Evaluate Treatment Response in Oncology ...

www.calyx.ai

— Join the discussion on irRecist with Calyx's Head of Oncology, Dr. Oliver Bohnsack and discover what's next in oncology research. › Journals

featured | 国际临床研究专业人员协会 - 中国及亚太区分会

acrpcap.org

— 13:15-13:55 RECIST and irRECIST in Cancer Therapy – Oliver Bohnsack, MD, PhD, MBA 13:55-14:40 Pursuit of Excellence in Oncology ... › category › fea...

Alle Infos zum Namen "Oliver Bohnsack"

Verwandte Suchanfragen zu Oliver Bohnsack

Katarina Ludajic
Axel Seuser
Doris Wiebke

Axel Hoos
Dirk Enge
Alexander Stein

Michael Binder
Chris Buckle
Christine Brown

Person "Bohnsack" (7)
Vorname "Oliver" (42674)
Name "Bohnsack" (389)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Oliver Bohnsack und Recist Person-Info